Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
15.45
-0.40 (-2.52%)
At close: Aug 10, 2026, 4:00 PM EDT
15.50
+0.05 (0.32%)
After-hours: Aug 10, 2026, 6:35 PM EDT
Aurinia Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Aurinia Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $17. The average 1-year stock price forecast is 10.03% higher than the current stock price, while the lowest is $15 (-2.91%) and the highest is $20 (+29.45%).
Price Target: $17 (+10.03%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Aurinia Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Hold Maintains $15 → $16 | Hold | Maintains | $15 → $16 | +3.56% | Aug 7, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $17 | Buy | Maintains | $17 | +10.03% | Aug 6, 2026 |
| Bloom Burton | Bloom Burton | Hold Maintains $15 | Hold | Maintains | $15 | -2.91% | May 11, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $17 | Buy | Reiterates | $17 | +10.03% | Feb 27, 2026 |
Financial Forecast
Revenue This Year
325.82M
from 283.06M
Increased by 15.11%
Revenue Next Year
383.79M
from 325.82M
Increased by 17.79%
EPS This Year
0.95
from 2.07
Decreased by -54.11%
EPS Next Year
1.11
from 0.95
Increased by 16.49%
EPS and Forward PE are based on non-GAAP adjusted numbers.